Therapeutic plasma exchange in rheumatic diseases: a university hospital experience

Therapeutic plasma exchange in rheumatic diseases: a university hospital experience

Abstract Introduction: Each day, evidence accumulates related to the use of therapeutic plasma exchange (TPE) in patients with rheumatic diseases. San Ignacio University Hospital has recorded all of the TPE sessions performed by the institution's apheresis group. Objective: To describe the TP...

Full description

Bibliographic Details
Main Authors:	Juan Pablo Córdoba, Carolina Larrarte, Cristina Estrada, Daniel G. Fernández-Ávila
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Reumatologia
Series:	Revista Brasileira de Reumatologia
Subjects:	Plasma exchange Rheumatic diseases Vasculitis Systemic lupus erythematosus Catastrophic antiphospholipid syndrome
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042017000500397&lng=en&tlng=en

Similar Items

Contraception for adolescents with chronic rheumatic diseases
by: Benito Lourenço, et al.

Multidisciplinary Unit Improves Pregnancy Outcomes in Women with Rheumatic Diseases and Hereditary Thrombophilias: An Observational Study
by: Isabel Añón-Oñate, et al.
Published: (2021-04-01)

Management of vasculitis in pregnancy
by: Nabnita Patnaik, et al.
Published: (2021-01-01)

Invasive fungal infections in children with rheumatic diseases
by: O. P. Kozlova, et al.
Published: (2021-01-01)

Periaortitis and diffuse subendocardial vasculitis in a patient with systemic lupus erythematosus – Lupus flare or a coexisting disease?
by: Ourania Gioti, et al.
Published: (2020-01-01)

Therapeutic plasma exchange in patients with pauciimmune vasculitis: Hospital Universitario San Ignacio experience; Bogotá, Colombia
by: Juan P. Córdoba, et al.
Published: (2014-05-01)

Hydrocephalus in an Elderly Man with Systemic Lupus Erythematosus
by: Wei-Sheng Chen, et al.
Published: (2009-06-01)

Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases
by: S V Moiseev, et al.
Published: (2013-05-01)

Outcomes of severe systemic rheumatic disease patients requiring extracorporeal membrane oxygenation
by: Pierre Bay, et al.
Published: (2021-02-01)

Potential adverse health consequences of climate change related to rheumatic diseases
by: Thomas Bush
Published: (2021-08-01)

ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01)

Primary antiphospholipid syndrome progressing to systemic lupus erythematosus: a case report
by: Rocco Manganelli, et al.
Published: (2013-04-01)

Echocardiographic Abnormalities and Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
by: Creso Abreu Falcão, et al.
Published: (2002-09-01)

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
by: M. Taraborelli, et al.
Published: (2016-12-01)

Lymphocytopenia is associated with anti-Beta-2 glycoprotein-1 in patients with 220 systemic lupus erythematosus
by: Thelma Skare, et al.
Published: (2016-07-01)

Hyperhomocysteinemia - an additional risk factor of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome
by: I. E. Shirokova, et al.
Published: (2003-08-01)

Blood nitrates content in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: D V Reshetnyak, et al.
Published: (2004-05-01)

CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH RITUXIMAB: CASE REPORT AND A REVIEW OF THE LITERATURE
by: Goran Sukara, et al.
Published: (2015-04-01)

Prevalence and clinical correlates of antiphospholipid antibodies in South Africans with systemic lupus erythematosus
by: Gould, Trevor John
Published: (2008)

Antiphospholipid syndrome and exogenic factors ofthromboses risk
by: E S Mach, et al.
Published: (2004-11-01)

Extensive abdominal wall ulceration as a late manifestation of antiphospholipid syndrome: a case report
by: Yogesh Sharma, et al.
Published: (2018-08-01)

Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases
by: Gholamreza Azizi, et al.
Published: (2015-10-01)

Regulatory B cells in autoimmune rheumatic diseases
by: Lazaros I. Sakkas
Published: (2017-01-01)

Reproductive health and pregnancy problems of systemic lupus erythematosus
by: И. Ю. Головач, et al.
Published: (2019-12-01)

Therapeutic Plasma Exchange in Patients with Systemic Lupus Erythematosus
by: Cheuk Man Ho, et al.
Published: (2020-12-01)

Clinical and endoscopic assessment of gastric state in systemic lupus erythematosus and antiphospholipid syndrome
by: I. A. Doroshkevich, et al.
Published: (2004-06-01)

The Prevalence of Anticardiolipin Antibody in Patients with Systemic Lupus Erythematosus and Its Association with Clinical Manifestations
by: Zahra Basiri, et al.
Published: (2013-01-01)

The Prevalence of Anticardiolipin Antibody in Patients with Systemic Lupus Erythematosus and Its Association with Clinical Manifestations
by: Zahra Basiri, et al.
Published: (2013-01-01)

Anesthetic management of patient with systemic lupus erythematosus and antiphospholipid antibodies syndrome for laparoscopic nephrectomy and cholecystectomy
by: Rashid Saeed Khokhar, et al.
Published: (2015-01-01)

Lupus and pregnancy in the 21st century
by: Savino Sciascia, et al.
Published: (2014-03-01)

Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus
by: Zahra Sayed Bonakdar, et al.
Published: (2011-01-01)

Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome
by: Takako Miyamae, et al.
Published: (2021-03-01)

Lupus eritematoso discóide na infância Discoid lupus erythematosus in childhood
by: Maria Carolina de A. Sampaio, et al.
Published: (2007-06-01)

IMMUNOINFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TYPE I INTERFERON: NEW EVIDENCE
by: E. L. Nasonov, et al.
Published: (2019-09-01)

Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study
by: Chung-Yuan Hsu, et al.
Published: (2019-10-01)

Anticardiolipine antibodies in skin and muscle eluates of patients with primary and secondary antiphospholipid syndrome
by: Z S Alekberova, et al.
Published: (2004-08-01)

Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?
by: Ilaria Mormile, et al.
Published: (2021-02-01)

According to the 2019 updated European League Against Rheumatism (EULAR) recommendations for the treatment of systemic lupus erythematosus: debatable issues and comments
by: T. V. Popkova, et al.
Published: (2019-11-01)

Call for Vigilance – Red Flags in Systemic Lupus Erythematous
by: Badar Hasan, et al.
Published: (2017-07-01)

Successful Treatment of Catastrophic Antiphospholipid Syndrome Using Rituximab: Case Report and Review of the Literature
by: Cristina Stanescu, et al.
Published: (2021-08-01)